Paper Review Records
All Paper Review Records
5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
301
days
Preformed donor-specific antibodies are associated with acute rejection and biliary complications after liver transplantation: A Swiss Transplant Cohort Study analysis
Authors
Julien Vionnet; Sylvie Ferrari-Lacraz; Linard David Hoessly; Antonio Mancarella; Yannick D. Müller; Stefan Schaub; Jakob Nilsson; Urs Wirthmüller; Susanne Stampf; Michael Koller; Nicolas J. Mueller; Myriam Amrari; Oriol Manuel; Dela Golshayan; Montserrat Fraga; Darius Moradpour; Nicolas Goossens; Giulia Magini; Philippe Compagnon; Valérie McLin; Nathalie Rock; Barbara Wildhaber; Andreas E. Kremer; Jose Oberholzer; Richard Xavier Sousa Da Silva; Pascale Tinguely; Loreta Kavaliukaite; Annalisa Berzigotti; Vanessa Banz; Christine Bernsmeier; Philipp Dutkowski; David Semela; Matthias Niemann; Giuseppe Pantaleo; Manuel Pascual; Jean Villard; and the Swiss Transplant Cohort Study (STCS)Show moreShow less
Affiliations
1. Transplantation Centre, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; 2. Service of Immunology and Allergy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; 3. Service of Gastroenterology and Hepatology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; 4. Transplant Immunology Unit and National Histocompatibility Laboratory of Reference, Geneva University Hospitals and University of Geneva, Geneva, Switzerland; 5. Swiss Transplant Cohort Study, University Hospital Basel, Basel, Switzerland; 6. HLA-Diagnostic and Immunogenetics Laboratory, University Hospital Basel, Basel, Switzerland; 7. Department of Immunology, University Hospital Zürich, Zürich, Switzerland; 8. Centre for Laboratory Medicine, University Hospital Bern, Bern, Switzerland; 9. Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, Zürich, Switzerland; 10. Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; 11. Service of Transplantation, Geneva University Hospitals and University of Geneva, Geneva, Switzerland; 12. Service of Gastroenterology and Hepatology, Geneva University Hospitals and University of Geneva, Geneva, Switzerland; 13. Department of Paediatrics, Gynaecology and Obstetrics, Geneva University Hospitals and University of Geneva, Geneva, Switzerland; 14. Department of Gastroenterology and Hepatology, University Hospital Zürich, University of Zürich, Zürich, Switzerland; 15. Department of Surgery and Transplantation, University Hospital Zürich, University of Zürich, Zürich, Switzerland; 16. Department of Visceral Surgery and Medicine, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland; 17. University Centre for Gastrointestinal and Liver Diseases, University Hospital Basel, Basel, Switzerland; 18. Division of Gastroenterology and Hepatology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland; 19. PIRCHE AG, Berlin, GermanyShow moreShow less
110
days
Comparative analysis of early post-transplant infections after DCD with hypothermic oxygenated liver perfusion and DBD liver transplantation: A retrospective cohort study
Authors
Stephanie Klinzing; Olivia J. Kotoun; Linard D. Hoessly; Andreas E. Kremer; Nicolas J. Mueller; Philipp Dutkowski; Rea Andermatt; Peter W. Schreiber; Daniel A. HofmaennerShow moreShow less
Affiliations
1. Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland; 2. Medical School, University of Zurich, Zurich, Switzerland; 3. Clinic for Transplantation Immunology and Nephrology, Basel University Hospital, Basel, Switzerland; 4. Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland; 5. Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; 6. Division of Visceral Surgery, University Digestive Health Care Center—Clarunis, University Hospital Basel, Basel, Switzerland; 7. Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, SwitzerlandShow moreShow less
116
days
Beyond rejection risk: Identifying ideal candidates for pretransplant immune checkpoint inhibitors for HCC
Authors
Laia Aceituno; Grainne M. O’Kane; Woo Jin Choi; Parissa Tarbizian; Roxana Bucur; Nadia Rukavina; Anudari Zorigtbaatar; Beatriz Mínguez; Arndt Vogel; Gonzalo SapisochinShow moreShow less
Affiliations
1. Division of Gastroenterology and Hepatology, Toronto General Hospital, Toronto, Ontario, Canada; 2. Ajmera Transplant Centre, Multi-organ transplant, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada; 3. Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain; 4. St. Vincent’s University Hospital and University College Dublin, Dublin, Ireland; 5. University Health Network, HPB Surgical Oncology, Toronto, Ontario, Canada; 6. Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA; 7. Liver Unit, Hospital Universitari Vall d’Hebron, Liver Diseases Groups, Vall d´Hebron Institut of Research (VHIR), Vall d´Hebron Barcelona Hospital Campus, Barcelona, Spain; 8. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain; 9. Department of Hepatology, Gastroenterology, Endocrinology & Infectious Diseases, Hannover Medical School, Hannover, Germany; 10. Department of General, Abdominal Surgery and Liver Transplantation, Hospital Universitario Vall d’Hebrón, Barcelona, SpainShow moreShow less
120
days
Safety and feasibility of duct-to-duct biliary anastomosis in pediatric liver transplantation: A single-center retrospective study
Authors
Shiming Gong; Lijie Ma; Bingran Wang; Sui Zhou; Qiang Xia; Mingxuan FengShow moreShow less
Affiliations
1. Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; 2. Shanghai Institute of Transplantation, Shanghai, China; 3. Shanghai Engineering Research Center of Transplantation and Immunology, Shanghai, ChinaShow moreShow less
107
days
Safety and efficacy of continuous infusion terlipressin (BIV201): A phase 2 trial in patients with decompensated cirrhosis and refractory ascites
Authors
Jasmohan S. Bajaj; Ethan M. Weinberg; K. Rajender Reddy; Andrew P. Keaveny; Michael K. Porayko; David Koch; Paul J. Thuluvath; Douglas A. Simonetto; Paolo Angeli; Sujit V. Janardhan; Eric S. Orman; Jeffrey Zhang; Susan Clausen; Elisa Dauphinée; Joseph M. Palumbo; Penelope MarkhamShow moreShow less
Affiliations
1. Division of Gastroenterology, Hepatology and Nutrition, Richmond VA Medical Center, Richmond, Virginia, USA; 2. Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University, Richmond, Virginia, USA; 3. Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; 4. Department of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA; 5. Department of Hepatology, Vanderbilt University, Nashville, Tennessee, USA; 6. Department of Gastroenterology, The Medical University of South Carolina, Charleston, South Carolina, USA; 7. Department of Digestive Health & Liver Disease, Mercy Medical Center, Baltimore, Maryland, USA; 8. Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA; 9. Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA; 10. Department of Internal Medicine and Hepatology, University of Padova, Padua, Italy; 11. Department of Internal Medicine, Division of Digestive Diseases and Nutrition, Rush University Medical Center, Chicago, Illinois, USA; 12. Department of Gastroenterology – Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA; 13. Department of Biostatistics, Princeton Pharmatech, Princeton, New Jersey, USA; 14. Department of Research & Development, BioVie Inc., Carson City, Nevada, USAShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days